Skip to content
Big Win Zone

Zimbabwe Rejects ‘One-Sided’ American Health Aid Deal Due to Data Concerns

Health aid illustration
The offered US financial assistance was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a substantial US health deal valued at $367m (272 million pounds) spanning five years because of Washington's insistence on confidential data.

This move was revealed after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "skewed".

An official spokesperson later clarified that the US was seeking genetic material for scientific study and profit but refused to share the resulting advantages from any future medical innovations.

"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has urged more dialogue to reach a deal suitable to both sides so the country's vital HIV programme can continue.

Broader Context

This development follows a similar situation in neighbouring Kenya, where a high court suspended a similar deal with the US after legal challenges were filed about the safety of citizens' health data.

After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and accountability.

As per statements, 16 African countries have to date signed these new agreements, representing over $18.3bn in committed funds.

Details of the Rejected Deal

The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of access to any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.

"In essence, our country would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our population should a future pandemic arise."

National Interest and International Frameworks

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems already set up via the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.

"This mechanism is designed to ensure that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We encourage further discussions with our American counterparts on how future collaboration could be structured in a way that respects the independence and interests of each country."

Medical Community Response

A leading public health body stated it recognised the official position, but urged that negotiations need to persist since much of the country's HIV programmes relied on international support.

"If technical issues exist, such as those involving data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it commented.

This impasse underscores the complex tensions between receiving vital international aid and protecting a country's data in an increasingly data-driven world.

About the author

Katie Carroll

A seasoned casino strategist with over a decade of experience in gaming analysis and player success stories.

Big Win Zone

Type to search articles.